Reset Map2 Results
2 Scheelevägen Medicon Village Skåne län, 223 63 SwedenImmunovia’s innovative multiplexing technology (IMMrayTM) uses a single drop of serum to simultaneously measure 400+ biomarkers and provide condensed diagnostic-, prognostic- and predictive biomarker signatures. The company Immunovia has been a listed company since 2015, with shares (as IMMNOV), traded on Nasdaq First North in Stockholm and now heading for the Nasdaq Stockholm main-list (Q1 2018). The company has 40+ employees, is headquartered in Lund, Sweden; and is currently setting up reference labs in both Lund, Sweden, and Boston, USA. Technology IMMray™ is a versatile and robust platform technology for performing clinical serum proteomics, developed and optimized over 17 years at Lund University/Create Health. In contrast to genomics microarray technologies (e.g. NGS) that measure the potential risk of a future disease/drug (Rx) response, IMMray™ multiplexes the patient serum proteome and assesses the actual current state of the disease/treatment response. The arrays are developed from a proprietary set (currently 970) recombinant single chain fragment variant (scFV) antibodies from our own phage-display library and are able to detect changes in immuno-regulatory factors, cytokines, enzymes, complement proteins, innate factors, and cancer associated proteins. Diagnostic workflow IMMray™ is optimized for routine diagnostic lab workflows with three day’s turnaround time (TAT) from patient sample received to test report. Disease areas IMMrayTM has shown its applicability within two main disease areas – oncology (pancreatic) and autoimmune s (rheumatoid arthritis, Systemic Lupus Erythematosus, vasculitis, Sjogrens Syndrome). The key advantages, using IMMrayTM includes the ability to work with serum samples as opposed to biopsies, and, the achievement of very high clinical sensitivities and specificities to successfully differentiate between phenotypically similar indications. Our pharma offerings For our pharma partners, we design Customized Discovery Chips and IMMray™ CDx Test solutions for patient cohort dichotomization. After an initial survey of our 400+ serum biomarkers, we use our proprietary bioinformatics tools to derive a specific condensed signature/algorithm of 5-35 proteins capable of differentiating patients into sub-cohorts. This enables patient selection with sensitivities and specificities above 95%. Initially, IMMray™ product testing will be performed through our reference laboratories in Lund, Sweden and Boston, USA.
26 Forest Street Marlborough, MA, 01752 United StatesImmunovia’s innovative multiplexing technology (IMMrayTM) uses a single drop of serum to simultaneously measure 400+ biomarkers and provide condensed diagnostic-, prognostic- and predictive biomarker signatures. The company Immunovia has been a listed company since 2015, with shares (as IMMNOV), traded on Nasdaq First North in Stockholm and now heading for the Nasdaq Stockholm main-list (Q1 2018). The company has 40+ employees, is headquartered in Lund, Sweden; and is currently setting up reference labs in both Lund, Sweden, and Boston, USA. Technology IMMray™ is a versatile and robust platform technology for performing clinical serum proteomics, developed and optimized over 17 years at Lund University/Create Health. In contrast to genomics microarray technologies (e.g. NGS) that measure the potential risk of a future disease/drug (Rx) response, IMMray™ multiplexes the patient serum proteome and assesses the actual current state of the disease/treatment response. The arrays are developed from a proprietary set (currently 970) recombinant single chain fragment variant (scFV) antibodies from our own phage-display library and are able to detect changes in immuno-regulatory factors, cytokines, enzymes, complement proteins, innate factors, and cancer associated proteins. Diagnostic workflow IMMray™ is optimized for routine diagnostic lab workflows with three day’s turnaround time (TAT) from patient sample received to test report. Disease areas IMMrayTM has shown its applicability within two main disease areas – oncology (pancreatic) and autoimmune s (rheumatoid arthritis, Systemic Lupus Erythematosus, vasculitis, Sjogrens Syndrome). The key advantages, using IMMrayTM includes the ability to work with serum samples as opposed to biopsies, and, the achievement of very high clinical sensitivities and specificities to successfully differentiate between phenotypically similar indications. Our pharma offerings For our pharma partners, we design Customized Discovery Chips and IMMray™ CDx Test solutions for patient cohort dichotomization. After an initial survey of our 400+ serum biomarkers, we use our proprietary bioinformatics tools to derive a specific condensed signature/algorithm of 5-35 proteins capable of differentiating patients into sub-cohorts. This enables patient selection with sensitivities and specificities above 95%. Initially, IMMray™ product testing will be performed through our reference laboratories in Lund, Sweden and Boston, USA.
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.